We are pleased to share an important milestone in the life of the geneTIGA project: the upcoming Final Meeting, which will take place in Rome on November 23–24, 2026.
The geneTIGA project will hold its Final Meeting in Rome on 23–24 November 2026, marking a key milestone in advancing European research in gene and cell therapy. The event will present the project’s final scientific results, with a strong focus on engineered T-cell approaches and next-generation gene editing strategies for immune-mediated diseases. Researchers, clinicians, and stakeholders will discuss how these breakthroughs can be translated into clinical applications and future therapeutic development pathways, while also fostering new collaborations across the European research landscape.
📍 Rome, Italy
📅 November 23–24, 2026